ES2114053T3 - Determinacion de actividades plaquetarias. - Google Patents

Determinacion de actividades plaquetarias.

Info

Publication number
ES2114053T3
ES2114053T3 ES93912364T ES93912364T ES2114053T3 ES 2114053 T3 ES2114053 T3 ES 2114053T3 ES 93912364 T ES93912364 T ES 93912364T ES 93912364 T ES93912364 T ES 93912364T ES 2114053 T3 ES2114053 T3 ES 2114053T3
Authority
ES
Spain
Prior art keywords
determination
platelets
methods
blood
procoagulant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93912364T
Other languages
English (en)
Inventor
Hendrik C Hemker
Robert J Wagenvoord
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Switzerland
Original Assignee
Dade Producktions AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Producktions AG filed Critical Dade Producktions AG
Application granted granted Critical
Publication of ES2114053T3 publication Critical patent/ES2114053T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2337/00—N-linked chromogens for determinations of peptidases and proteinases
    • C12Q2337/10—Anilides
    • C12Q2337/12—Para-Nitroanilides p-NA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96444—Factor X (3.4.21.6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974—Thrombin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04—Phospholipids, i.e. phosphoglycerides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE PREVEN METODOS PARA MEDIR LA ACTIVIDAD PRO-COAGULANTE DE PLAQUETAS EN LA SANGRE POR MEDIO DE UN ANALISIS CROMOGENICO QUE ES ESPECIFICO PARA FOSFOLIPIDOS PRO-COAGULANTES. ESTOS METODOS INCLUYEN LA DETERMINACION DE LA ACTIVIDAD DE REPOSO Y/O EXCITABILIDAD DE LAS PLAQUETAS, LO QUE DETERMINA EL UMBRAL EN EL QUE LOS FACTORES DE ACTIVACION DE COAGULACION (CIRCULANTES EN SANGRE) SON PELIGROSOS. TAMBIEN SE PREVEN METODOS PARA MEDICAMENTOS DE PROTECCION POR SU EFECTO POTENCIAL INHIBITORIO SOBRE LA ACTIVACION DE PLAQUETAS.
ES93912364T 1992-06-03 1993-06-03 Determinacion de actividades plaquetarias. Expired - Lifetime ES2114053T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/892,865 US5266462A (en) 1992-06-03 1992-06-03 Measurement of platelet activities
PCT/US1993/005436 WO1993024840A1 (en) 1992-06-03 1993-06-03 Measurement of platelet activities

Publications (1)

Publication Number Publication Date
ES2114053T3 true ES2114053T3 (es) 1998-05-16

Family

ID=25400634

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93912364T Expired - Lifetime ES2114053T3 (es) 1992-06-03 1993-06-03 Determinacion de actividades plaquetarias.

Country Status (9)

Country Link
US (1) US5266462A (es)
EP (1) EP0605674B1 (es)
JP (1) JP3143694B2 (es)
AT (1) ATE162632T1 (es)
AU (1) AU658073B2 (es)
CA (1) CA2114719C (es)
DE (1) DE69316572T2 (es)
ES (1) ES2114053T3 (es)
WO (1) WO1993024840A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9306053D0 (en) * 1993-03-24 1993-05-12 Nycomed Pharma As Method and assay
ES2139957T3 (es) 1994-07-23 2000-02-16 Roche Diagnostics Gmbh Metodo para la determinacion del estado pretrombotico.
US5763199A (en) * 1994-09-29 1998-06-09 Mount Sinai School Of Medicine Of The City University Of New York Platelet blockade assay
WO1997041432A1 (en) * 1996-04-30 1997-11-06 Medtronic, Inc. Method for determining platelet inhibitor response
US6221672B1 (en) 1996-04-30 2001-04-24 Medtronic, Inc. Method for determining platelet inhibitor response
US5951951A (en) 1997-04-30 1999-09-14 Medtronic, Inc. Platelet function evaluation technique for citrated whole blood
US6010911A (en) * 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
AU8388098A (en) * 1997-07-11 1999-02-08 Mount Sinai School Of Medicine Of The City University Of New York, The Assays for diagnosis of thrombophilic disease
US20040219681A1 (en) * 1997-09-18 2004-11-04 Ridgway Helen Jane Two-tube method and system for platelet function analysis using platelet count
US20040219682A1 (en) * 1997-09-18 2004-11-04 Ridgway Helen Jane Single-tube method and system for platelet function analysis
US6410337B1 (en) * 1997-09-18 2002-06-25 Helena Laboratories Corporation Method of platlet function analysis using platelet count
AU2900599A (en) * 1998-03-10 1999-09-27 Baxter International Inc. Thrombin preparation and products and fibrin sealant methods employing same
WO2001044493A2 (en) * 1999-12-15 2001-06-21 Pentapharm Ag Hematological assay and reagent
JP2005538383A (ja) * 2002-09-10 2005-12-15 プラコア・インコーポレーテッド 血小板機能を監視する方法および装置
US20070243632A1 (en) * 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
US7790362B2 (en) 2003-07-08 2010-09-07 Accumetrics, Inc. Controlled platelet activation to monitor therapy of ADP antagonists
US7422905B2 (en) 2004-02-27 2008-09-09 Medtronic, Inc. Blood coagulation test cartridge, system, and method
US7439069B2 (en) 2004-02-27 2008-10-21 Nippoldt Douglas D Blood coagulation test cartridge, system, and method
US7399637B2 (en) 2004-04-19 2008-07-15 Medtronic, Inc. Blood coagulation test cartridge, system, and method
CA2566411A1 (en) * 2004-05-11 2005-11-24 Heptest Laboratories, Inc. Compositions, kit and one-step method for monitoring compounds having anti-factor xa and/or anti factor iia activities
WO2005116623A2 (en) * 2004-05-17 2005-12-08 Medtronic, Inc. Point of care heparin determination system
EP1875232A2 (en) * 2005-04-25 2008-01-09 PlaCor, Inc. Methods and devices for monitoring platelet function
US20100099130A1 (en) * 2006-10-25 2010-04-22 Placor Inc. Methods and devices for monitoring platelet function

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4900679A (en) * 1983-01-26 1990-02-13 University Of Medicine And Dentistry Of New Jersey Method for determining the existence and/or the monitoring of a pathological condition in a mammal and a test kit therefor
US4728660A (en) * 1984-06-11 1988-03-01 University Of Miami Method of treating diseases arising from platelet hyperactivation
ES8702431A1 (es) * 1984-09-21 1986-12-16 Boehringer Ingelheim Int Procedimiento para preparar una proteina inhibidora de la coagulacion de la sangre
US5066788A (en) * 1984-09-21 1991-11-19 Boehringer Ingelheim International Gmbh Blood coagulation inhibiting proteins, processes for preparing them and their uses
US4871677A (en) * 1985-02-25 1989-10-03 Hemotec, Inc. Method of collecting and analyzing a sample of blood when monitoring heparin therapy
US5017556A (en) * 1986-11-04 1991-05-21 Genentech, Inc. Treatment of bleeding disorders using lipid-free tissue factor protein
US4880788A (en) * 1987-10-30 1989-11-14 Baylor College Of Medicine Method for preventing and treating thrombosis
US5120537A (en) * 1989-06-14 1992-06-09 Oklahoma Medical Research Foundation Factor xa based anticoagulant compositions

Also Published As

Publication number Publication date
DE69316572T2 (de) 1998-09-10
AU658073B2 (en) 1995-03-30
JP3143694B2 (ja) 2001-03-07
DE69316572D1 (de) 1998-02-26
JPH06509479A (ja) 1994-10-27
AU4409093A (en) 1993-12-30
ATE162632T1 (de) 1998-02-15
CA2114719C (en) 1997-08-26
EP0605674A1 (en) 1994-07-13
CA2114719A1 (en) 1993-12-09
US5266462A (en) 1993-11-30
WO1993024840A1 (en) 1993-12-09
EP0605674B1 (en) 1998-01-21

Similar Documents

Publication Publication Date Title
ES2114053T3 (es) Determinacion de actividades plaquetarias.
DE3771185D1 (de) Optischer detektor zur gleichzeitigen erfassung von herzschlag und toraxbewegung.
DE69008664D1 (de) Bestrahlung von bluterzeugnissen.
DK531887A (da) Mutagenese- og screeningsfremgangsmaade samt produkt
FI905531A0 (fi) Transdermalisk anvaendning av 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobensotiazol.
DE3765138D1 (de) Mehrschichtiges element zur quantitativen analyse von immunoreagenzien.
DE69013294D1 (de) Doppler-Radar zur Entdeckung und Ortung von Hubschraubern.
DE3667605D1 (de) Windel zur verhuetung von wundliegen.
DK314887D0 (da) Kompleksforbindelser, farmaceutiske midler med indhold heraf samt fremgangsmaade til fremstilling heraf
DE3783966D1 (de) Reagens zur pruefung von periodentalen erkrankungen.
ES2018137A4 (es) Procedimiento y dispositivo para analizar y medir el tiempo de coagulacion de la sangre.
DK226889A (da) Alkoholpeptidderivat samt anvendelse deraf til mindskning af blodkoagulation
DE3481556D1 (de) System zur unterscheidung und zur lagebestimmung von objekten.
DE3852625D1 (de) Vektoren und Verbindungen zur Expression von Zymogen-Formen von menschlichem Protein C.
NO865183D0 (no) Styresystem for styring av et en- eller tosporet kjoeretoey.
DE68910100D1 (de) Mittel zur Bluttrennung.
NO921993L (no) Fremgangsmaate for efterbehandling av amfotaere eller zwitterioniske tensider
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
NO931774D0 (no) Reagens for bestemmelse av aptt
DE68908764D1 (de) Pufferlösungssysteme und Elektrolyten zur Eichung von Analysegeräten.
NO931772L (no) Anvendelse av protrombinfragmenter
DE3789189D1 (de) Flüssigkeitssteuerung und gedämpfter Flüssigkeitsweg.
IT1216742B (it) Dispositivo e procedimento per la realizzazione estemporanea di testdiagnostici quantitativi sul sangue intero.
DE3850429D1 (de) Verhinderung von ADP-Ribosylierung von G-Proteinen.
FI903637A0 (fi) Diagnostiska analysfoerfarande och deras anvaendning foer bestaemning av kliniska tillstaond.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 605674

Country of ref document: ES